Search Results - "Montal, R."

1913 Pre and post neoadjuvant endocrine therapy (NET) biomarkers in breast cancer to better predict distant progression: A retrospective study by Montal, R, Rivas, G, Petit, A, Soler, T, Perez, J, Morilla, I, Guma, A, Pla, M.J, Gil, M

Get full text

Molecular predictors of recurrence prevention with sorafenib as adjuvant therapy in hepatocellular carcinoma: Biomarker study of the STORM phase III trial by Pinyol, R, Montal, R, Takayama, T, Chau, G.-Y, Mazzaferro, V, Roayaie, S, Lee, H.C, Poon, R.T.-P, Kokudo, N, Zhang, Z, Bassaganyas, L, Torrecilla, S, Moeini, A, Rodriguez-Carunchio, L, Gane, E, Verslype, C, Croitoru, A.E, Cillo, U, de la Mata, M, Lupo, L, Strasser, S, Park, J.-W, Camps, J, Solé, M, Thung, S.N, Villanueva, A, Pena, C, Meinhart, G, Bruix, J, Llovet, J.M

Get full text

Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab by Montal, R., Oliva, M., Taberna, M., De Avila, L., Rovira, A., Cos, M., Mañós, M., Navarro, V., Nogués, J., Lozano, A., Rodríguez, L., Vilajosana, E., Vázquez, S., Mesia, R.

“…Purpose Management of residual neck disease (RND) is one of the unsolved points after bio-radiotherapy (BRT) in loco-regional advanced squamous-cell carcinoma…”
Get full text

P-189 Surrogate endpoints in advanced gastroesophageal cancer: A systematic review and meta-analysis of phase III clinical trials by Veas, J., Prieto, A., Bonet, M., García, M. Díez, Salud, A., Montal, R.

Get full text

PD-2 Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies by Veas, J., Piñol, M., Sorolla, M., Parisi, E., Sorolla, A., Santacana, M., Ruiz, M., Parra, G., Aracil, C., Escartin, A., Vilardell, F., Salud, A., Montal, R.

Get full text

Abstract P4-08-08: Biomarkers to predict distant recurrence free survival after neoadjuvant endocrine therapy in breast cancer. A long follow up retrospective study by Gil-Gil, M, Morilla, I, Petit, A, Soler, T, Perez-Martin, X, Guma, A, Pla, MJ, Ortega, R, Garcia-Tejedor, A, Falo, C, Montal, R, Perez-Casanova, L, Loayza, C, Pernas, S

“…Abstract Background: Neoadjuvant endocrine therapy (NET) is gaining more acceptances for the management of estrogen receptor (ER) positive breast cancer (BC)…”
Get full text

P-146 Stenting metastatic bile duct obstruction (BDO): the importance of liver function parameters by Bergamino Sirven, M., Montal, R., Galan, M., Gornals Soler, J., Escalante Porrua, E., Navarro Perez, V., Marin Melia, M.

Get full text

Integrative molecular classification of extrahepatic cholangiocarcinoma by Montal, R., Leow, W.Q., Montironi, C., Bassaganyas, L., Moeini, A., Sia, D., Pinyol, R., Cabellos, L., Peix, J., Maeda, M., Tabrizian, P., Minguez, B., Pawlik, T., Labgaa, I., Roberts, L., Sole, M., Fiel, M.I., Thung, S., Roayaie, S., Villanueva, A., Schwartz, M., Llovet, J.M.

Get full text

GS-004 - Integrative molecular classification of extrahepatic cholangiocarcinoma by Montal, R., Leow, W.Q., Montironi, C., Bassaganyas, L., Moeini, A., Sia, D., Pinyol, R., Cabellos, L., Peix, J., Maeda, M., Tabrizian, P., Minguez, B., Pawlik, T., Labgaa, I., Roberts, L., Sole, M., Fiel, M.I., Thung, S., Roayaie, S., Villanueva, A., Schwartz, M., Llovet, J.M.

Get full text

Comorbidity and nutritional factors influence on bioradiotherapy (BRT) outcome in head and neck squamous cell carcinoma (HNSCC) patients by Oliva, M., Taberna, M., Iriarte, A.J. Rullan, Bergamino, M., Rovira, A., Montal, R., Hurtos, L., Arribas, L., Vilajosana, E., Lozano, A., Navarro, V., Vazquez, S., Maños, M., Mesía, R.

Get full text

P-195 SPRY2 and response to FOLFOX/CAPOX in metastatic KRAS mutated colorectal cancer by Montal, R., Merche, M.-V., Anta, B., Martínez, N., Santos, C., Sanjuan, X., Paúles, M.J., Pérez Martín, F.J., Azuara, D., Salazar, R., Rojas, J.M.

Get full text

PS-022 - Molecular predictors of recurrence prevention with sorafenib as adjuvant therapy in hepatocellular carcinoma: Biomarker study of the STORM phase III trial by Pinyol, R., Montal, R., Takayama, T., Chau, G.-Y., Mazzaferro, V., Roayaie, S., Lee, H.C., Poon, R.T.-P., Kokudo, N., Zhang, Z., Bassaganyas, L., Torrecilla, S., Moeini, A., Rodriguez-Carunchio, L., Gane, E., Verslype, C., Croitoru, A.E., Cillo, U., de la Mata, M., Lupo, L., Strasser, S., Park, J.-W., Camps, J., Solé, M., Thung, S.N., Villanueva, A., Pena, C., Meinhart, G., Bruix, J., Llovet, J.M.

Get full text

992PDRESIDUAL NECK DISEASE (RND) MANAGEMENT IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) TREATED WITH RADIOTHERAPY (RT) PLUS CETUXIMAB (C) by Montal, R., De Avila, L., Taberna, M., Oliva, M., Rovira, A., Cos, M., Mañós, M., Navarro, V., Nogués, J., Lozano, A., Vázquez, S., Mesia, R.

“…Abstract Aim: RND is one of the unsolved points in the bioradiotherapy of locoregionally advanced SCCHN. After this treatment, neck dissection (ND) could…”
Get full text

Residual Neck Disease (Rnd) Management in Squamous-Cell Carcinoma of the Head and Neck (Scchn) Treated with Radiotherapy (Rt) Plus Cetuximab (C) by Montal, R., De Avila, L., Taberna, M., Oliva, M., Rovira, A., Cos, M., Mañós, M., Navarro, V., Nogués, J., Lozano, A., Vázquez, S., Mesia, R.

Get full text

O-012 Nanofluidic digital PCR and extended genotyping of RAS, BRAF and PI3KCA for improved selection of metastatic colorectal cancer patients to anti-EGFR therapies by Azuara, D., Santos, C., Lopez-Doriga, A., Grasselli, J., Nadal, M., Sanjuan, X., Marin, F., Morell, M., Montal, R., Moreno, V., Montagut, C., Bellosillo, B., Argiles, G., Elez, E., Tabernero, J., Capellá, G., Salazar, R.

Get full text